Kilitch Drugs (India) Limited share

Kilitch Drugs (India) Limited

Live Kilitch Drugs (India) Limited Share Price Chart

Kilitch Drugs (India) Limited Share Performance

Today's Low Today's High
346.00 346.75
364.00 358.50
52 Week Low 52 Week High
300.00 (26-Nov-2024) 293.95 (13-Feb-2025)
404.95 (12-Sep-2024) 404.90 (12-Sep-2024)

Open
364.00 355.60
Previous Close
353.15 355.60
Volume
0.14
Total Traded value
0.48 (Lakhs)
Upper circuit
423.75 426.80
Lower circuit
282.55 386.20

Kilitch Drugs (India) Limited Share Market Depth

Buy Order Quantity Sell Order Quantity
967
414

Bid PriceQuantity
0.000.00
0.000.00
0.000.00
0.000.00
0.000.00
Total:967
Ask PriceQuantity
0.000.00
0.000.00
0.000.00
0.000.00
0.000.00
Total:414

Kilitch Drugs (India) Limited Share Fundamentals

Market Cap: 5.64 Cr
PE Ratio (TTM): 24.42
PB Ratio: 2.42
Industry P/E:31.52
Debt to Equity:-
ROE:9.89
EPS (TTM):14.57
Book Value:58.48
Face Value: 10.00

Kilitch Drugs (India) Limited Stock Financials

Sep, 2023Sep, 2023Dec, 2022Sep, 2023Sep, 2022
Revenue75.72 Cr193.23 Cr12.88 Cr14.47 Cr22.43 Cr
Profit4.59 Cr-6.43 Cr0.33 Cr6.09 Cr3.64 Cr
Expense69.78 Cr202.47 Cr14.62 Cr41.78 Cr19.83 Cr
Comprehensive income4.58 Cr-6.42 Cr0.32 Cr-48.91 Cr5.07 Cr
EPS2.91-0.280.610.022.34
Kilitch Drugs (India) Limited is a pharmaceutical company based in Mumbai, India. We specialize in the development and operation of various pharmaceutical products. Our product portfolio includes a wide range of parenteral and nasal products, such as gastroenterology, anti-inflammatory, anticonvulsant/antiepileptic, anti-malarial, antibacterial, and anti-hypertensive drugs. We also offer diagnostic, sympathomimetic, local anesthetic, neurotonic, uterine stimulant, and external preparation drugs, as well as vaccines and veterinary products.

Our parenteral and nasal products are available in the form of liquid ampoules, vials, and dry powder injectables. We also provide iron supplements for the treatment of anemia, metered nasal drops, and products like Klavmox and Onecef. Additionally, we offer a range of oral formulations, including tablets, capsules, dry syrup, gripe water, and oral powder and liquid, in areas such as antibiotics, anti-diabetics, cardiovascular, and more.

Furthermore, we have effervescent tablets and powders like ROIPAR, DUREGRA, ROIVIT, and PH-7, as well as nutritional products like CELTINE. Our C-Seal product is a topical skin adhesive that securely holds skin edges without leaving marks from sutures and incisions. We also have a line of cosmetics and herbal products, including oils, lotions, liquids, creams, and paste for skin, personal, and hair care. These herbal products are used for various conditions such as sore throat, prostate problems, diabetes, obesity, and libido.

In addition to serving the domestic market, we also export our products. Kilitch Drugs (India) Limited was established in 1978 and has since become a trusted name in the pharmaceutical industry. Our commitment to quality and innovation drives us to continually develop and provide effective healthcare solutions.
Company nameListing dateIndustry NSE symbol BSE symbol
Kilitch Drugs (India) Limited Sep, 2010 May, 1994 Pharmaceuticals Pharmaceuticals KILITCH KILITCH

Kilitch Drugs (India) Limited Stock Shareholding pattern

Sep, 2023 Jul, 2023 Jun, 2023 Mar, 2023 Dec, 2022

  • Promoters 
    69.23%
    Public 
    30.77%
    Shares held by Employee Trusts 
    0.00%
  • Promoters 
    69.23%
    Public 
    30.77%
    Shares held by Employee Trusts 
    0.00%
  • Promoters 
    68.25%
    Public 
    31.75%
    Shares held by Employee Trusts 
    0.00%
  • Promoters 
    68.25%
    Public 
    31.75%
    Shares held by Employee Trusts 
    0.00%
  • Promoters 
    68.25%
    Public 
    31.75%
    Shares held by Employee Trusts 
    0.00%

Kilitch Drugs (India) Limited Share FAQ's

What is the range of today's stock performance for Kilitch Drugs (India) Limited?

Today's stock performance witnessed a fluctuation from a minimum of 346.00 on the NSE (National Stock Exchange) to a maximum of 364.00. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 346.75 to a high of 358.50.

What are the 52-week low and high values for Kilitch Drugs (India) Limited?

The stock's performance over the past 52 weeks reveals a low of 300.00 (occurred on 26-Nov-2024) and a high of 404.95 (achieved on 12-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 293.95 (on 13-Feb-2025), and the 52-week high is 404.90 (on 12-Sep-2024).

What was the opening and previous closing prices for Kilitch Drugs (India) Limited?

The stock's performance over the past 52 weeks reveals a low of 300.00 (occurred on 26-Nov-2024) and a high of 404.95 (achieved on 12-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 293.95 (on 13-Feb-2025), and the 52-week high is 404.90 (on 12-Sep-2024).

What is the total volume and traded value for Kilitch Drugs (India) Limited for the day?

The total volume is 0, and the total traded value is 0.48 ( Lakhs).

What are the upper and lower circuit limits for Kilitch Drugs (India) Limited?

The upper circuit limit is 423.75, and the lower circuit limit is 282.55.

What is the market cap and PE ratio for Kilitch Drugs (India) Limited?

The market cap is 5.64 Cr, and the PE ratio (TTM) is 31.52.

What is the PB ratio, industry P/E, and debt to equity ratio for Kilitch Drugs (India) Limited?

The PB ratio is 6.00, industry P/E is 31.52 .

What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Kilitch Drugs (India) Limited?

ROE is 9.89, EPS is 14.57, book value is 58.48

What are the revenue and profit figures for the latest quarter and previous quarters for Kilitch Drugs (India) Limited?

In Sep 2023, Revenue is 757223000.00, and Profit is 45945000.00. In Sep 2023, Revenue is 1932300000.00, and Profit is -64300000.00.

When was Kilitch Drugs (India) Limited listed, and what industry does it belong to?

The company, Kilitch Drugs (India) Limited, was listed in Sep 2010 and belongs to the Pharmaceuticals industry. Its NSE symbol is KILITCH.

What is the current shareholding pattern of the Kilitch Drugs (India) Limited?

As of latest available update, promoters hold 69.23%, the public holds 30.77%, and Employee Trusts holds 0.00.

The Indian Community

Public Community

Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.

Members
44
online
82
Threads
310
Settings
Back
Top